INTERNATIONAL PATENT: ABLYNX NV FILES APPLICATION FOR "IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING CEACAM5"

GENEVA, July 2 -- ABLYNX NV (Technologiepark 219052 Zwijnaarde) filed a patent application (PCT/EP2024/088111) for "IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING CEACAM5" on Dec 20, 2024. With publication no. WO/2025/133252, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NIEBEL, Bjorn (c/o Ablynx NVPatent Department,Technologiepark 219052 Ghent-Zwijnaarde), DE TAVERNIER, Evelyn (c/o Ablynx NVPatent DepartmentTechnologiepark 219052 Ghent-Zwijnaarde), VIGNE, Emmanuelle (c/o SANOFI46 avenue de la Grande Armee75017 Paris)...